Response to Asgari (Letter)

Loading...
Thumbnail Image
File version

Accepted Manuscript (AM)

Author(s)
Youlden, Danny R
Baade, Peter D
Soyer, H Peter
Youl, Philippa H
Kimlin, Michael G
Aitken, Joanne F
Green, Adele C
Khosrotehrani, Kiarash
Primary Supervisor
Other Supervisors
Editor(s)
Date
2017
Size
File type(s)
Location
Abstract

We wish to clarify key points raised in a recent commentary (Asgari, 2016) about our report on survival outcomes after multiple primary invasive melanomas (Youlden et al., 2016) published in the November 2016 issue of The Journal of Investigative Dermatology.

Journal Title

The Journal of Investigative Dermatology

Conference Title
Book Title
Edition
Volume

137

Issue

4

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© 2017 Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence (http://creativecommons.org/licenses/by-nc-nd/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, providing that the work is properly cited.

Item Access Status
Note
Access the data
Related item(s)
Subject

Clinical sciences

Oncology and carcinogenesis

Science & Technology

Life Sciences & Biomedicine

Dermatology

Survival

Persistent link to this record
Citation

Youlden, DR; Baade, PD; Soyer, HP; Youl, PH; Kimlin, MG; Aitken, JF; Green, AC; Khosrotehrani, K, Response to Asgari (Letter), The Journal of Investigative Dermatology, 2017, 137 (4), pp. 965-966

Collections